JeanMarie Guenot, Ph.D. is the current president and the CEO of Amphivena Therapeutics Inc. The company is based in San Francisco, and it deals with therapies for cancer treatment. JeanMarie has been in the industry for over 20 years. She has worked in both private and public sectors. Today, she is involved in project management, commercial development, Pharmaceuticals R&D and venture capital. JeanMarie is also an owner of the company known as Guenot LLC, which concentrates on the provision of specialized consultations services like project management, mergers and acquisitions, financial alliance services and financial planning to biotechnology and pharmaceutical companies.
According to her Linked In profile, Jeanmarie Guenot studied Physical and Medicinal Chemistry, and majored in drug design, protein structure and prediction, X-ray, NMR and quantum mechanical and Semi-empirical methods. She acquired her MBA from Wharton School, University of Pennsylvania and a Ph.D. from the University of California San Francisco.
JeanMarie Guenot kicked off her medical career at Hoffmann-La Roche. Here, she was the principle scientist in pre-clinical R&D. while she served the position, she was able to come up with drugs for oncology, autoimmune diseases, inflammation and metabolic diseases. JeanMarie started off her career in business as a manager at Atlas Venture. Here she managed the venture capital division. She has been able to join her two careers, and the result was the creation of science companies.
JeanMarie had worked for various companies before she was appointed as the President and the CEO Amphivena. She worked as a Vice-president of Corporate and Business Development at PDL BioPharma. During this period, she played a significant role in easing the process of licensing, mergers and acquisitions as well as alliance management of R&D commercial portfolios. She made a 50:50 deal between PDL and Hoffmann-La Roche; an agreement that benefited the two companies to commercialize and develop their drugs.
JeanMarie Guenot has had a success life as well as career. She has worked in two different industries and managed to bring out the best in each. She was awarded for Deal of Distinction in 2006 from Licensing Executive Society and BioBusiness Network Innovative Bio-Partnering award in 2005.
Read about Jeanmarie’s latest project on MarketWired in their article Amphivena Therapeutics Achieves Development Milestones Under Agreement With Janssen